Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Jongh, R. T.
Right arrow Articles by Stehouwer, C. D.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Jongh, R. T.
Right arrow Articles by Stehouwer, C. D.A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 53:2873-2882, 2004
© 2004 by the American Diabetes Association, Inc.

Free Fatty Acid Levels Modulate Microvascular Function

Relevance for Obesity-Associated Insulin Resistance, Hypertension, and Microangiopathy

Renate T. de Jongh1, Erik H. Serné1, Richard G. IJzerman1, Greetje de Vries1, and Coen D.A. Stehouwer1,2

1 Department of Internal Medicine and Institute for Cardiovascular Research, Vrije Universiteit University Medical Center, Amsterdam, the Netherlands
2 Department of Internal Medicine and Cardiovascular Research Institute Maastricht, Maastricht University Hospital, Maastricht, the Netherlands

To test the hypothesis that free fatty acids (FFAs) modulate microvascular function and that this contributes to obesity-associated insulin resistance, hypertension, and microangiopathy, we examined the effects of both FFA elevation in lean women and FFA lowering in obese women on skin microvascular function. A total of 16 lean and 12 obese women underwent, respectively, Intralipid plus heparin (or saline) infusion and overnight acipimox (or placebo) treatment. We measured capillary recruitment with capillaroscopy and endothelium-(in)dependent vasodilation by iontophoresis of acetylcholine and sodium nitroprusside before and during hyperinsulinemia (40 mU · m–2 · min–1). FFA elevation impaired capillary recruitment and acetylcholine-mediated vasodilation before (44.6 ± 16.8 vs. 56.9 ± 18.9%, P < 0.05; and 338 ± 131 vs. 557 ± 162%, P < 0.01, respectively) and during (54.0 ± 21.3 vs. 72.4 ± 25.4%, P < 0.01; and 264 ± 186 vs. 685 ± 199%, P < 0.01, respectively) hyperinsulinemia. FFA lowering improved capillary recruitment before (50.9 ± 14.6 vs. 37.4 ± 9.3%, P < 0.01) and during (66.8 ± 20.6 vs. 54.8 ± 15.4%, P < 0.05) hyperinsulinemia. Changes in FFA levels were inversely associated with changes in capillary recruitment and insulin sensitivity in lean (r = –0.46, P = 0.08; and r = –0.56, P = 0.03) and in obese (r = –0.70, P = 0.02; and r = –0.62, P = 0.04) women. Regression analyses showed that changes in capillary recruitment statistically explained ~29% of the association between changes in FFA levels and insulin sensitivity. In conclusion, FFA levels modulate microvascular function and may contribute to obesity-associated insulin resistance, hypertension, and microangiopathy.


Address correspondence and reprint requests to Prof. Dr. Coen D.A. Stehouwer, Department of Medicine, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, Netherlands. E-mail: cda.stehouwer{at}vumc.nl


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
PhysiologyHome page
A. M. Jonk, A. J. H. M. Houben, R. T. de Jongh, E. H. Serne, N. C. Schaper, and C. D. A. Stehouwer
Microvascular Dysfunction in Obesity: A Potential Mechanism in the Pathogenesis of Obesity-Associated Insulin Resistance and Hypertension
Physiology, August 1, 2007; 22(4): 252 - 260.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. Muniyappa, M. Montagnani, K. K. Koh, and M. J. Quon
Cardiovascular Actions of Insulin
Endocr. Rev., August 1, 2007; 28(5): 463 - 491.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
E. H. Serne, R. T. de Jongh, E. C. Eringa, R. G. IJzerman, and C. D.A. Stehouwer
Microvascular Dysfunction: A Potential Pathophysiological Role in the Metabolic Syndrome
Hypertension, July 1, 2007; 50(1): 204 - 211.
[Full Text] [PDF]


Home page
EndocrinologyHome page
W. Chai and Z. Liu
p38 Mitogen-Activated Protein Kinase Mediates Palmitate-Induced Apoptosis But Not Inhibitor of Nuclear Factor-{kappa}B Degradation in Human Coronary Artery Endothelial Cells
Endocrinology, April 1, 2007; 148(4): 1622 - 1628.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M.F. Oliver
Sudden cardiac death: the lost fatty acid hypothesis
QJM, October 1, 2006; 99(10): 701 - 709.
[Abstract] [Full Text] [PDF]


Home page
J Mol EndocrinolHome page
R. M Luque, M. D Gahete, R. J Valentine, and R. D Kineman
Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
J. Mol. Endocrinol., August 1, 2006; 37(1): 25 - 38.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. L. Wang, L. Zhang, K. Youker, M.-X. Zhang, J. Wang, S. A. LeMaire, J. S. Coselli, and Y. H. Shen
Free Fatty Acids Inhibit Insulin Signaling-Stimulated Endothelial Nitric Oxide Synthase Activation Through Upregulating PTEN or Inhibiting Akt Kinase.
Diabetes, August 1, 2006; 55(8): 2301 - 2310.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart J SupplHome page
M. D. Jensen
Adipose tissue as an endocrine organ: implications of its distribution on free fatty acid metabolism
Eur. Heart J. Suppl., May 1, 2006; 8(suppl_B): B13 - B19.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. B. Meigs, C. J. O'Donnell, G. H. Tofler, E. J. Benjamin, C. S. Fox, I. Lipinska, D. M. Nathan, L. M. Sullivan, R. B. D'Agostino, and P. W.F. Wilson
Hemostatic Markers of Endothelial Dysfunction and Risk of Incident Type 2 Diabetes: The Framingham Offspring Study
Diabetes, February 1, 2006; 55(2): 530 - 537.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2004 by the American Diabetes Association.